我们的网站为什么显示成这样？

可能因为您的浏览器不支持样式，您可以更新您的浏览器到最新版本，以获取对此功能的支持，访问下面的网站，获取关于浏览器的信息：

|本期目录/Table of Contents|

血管紧张素Ⅱ受体亚型Ⅰ拮抗剂及其临床应用(PDF)

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
1997年第1期
页码:
24-26
栏目:
综述
出版日期:
1997-01-01

文章信息/Info

Title:
-
作者:
苏哲坦 综述
海南省人民医院心内科　海口 570311
Author(s):
-
关键词:
血管紧张素Ⅱ 　受体;  AT1 　受体拮抗剂　抑制剂　综述文献
Keywords:
-
分类号:
-
DOI:
-
文献标识码:
-
摘要:
-
Abstract:
-

参考文献/References

［1］猿田享男. ァンジォテンシンⅡ受容体拮抗药.内科, 1995; 75: 69.

［2］ Kang PM , Landan AJ , Eberhardt RT , et al.Angiotensin Ⅱ receptor antagonists: a new approach to blockade of the renin-angiotensin system. Am Heart J , 1994; 127: 1388.

［3］Hirsch TA , Pint YM , Schunkert H, et al. Potential role of the tissue renin-angiotensin system in the pathophysiology of congestive heart failure. Am J Cardiol, 1990; 66: 220.

［4］Streeten DHP, Anderson GH, Freiberg JM , et al. Use of angiotensin Ⅱantagonist (saralasin)in the recognition of“angiotensinogenic”hypertension. N Engl J Med , 1975; 292: 657.

［5］Laragh JH, Keeman R. Angiotensin Ⅱ blockade in man by sar1-ala8-angiotensin for understanding and treatment of high blood-pressure.Lancet, 1973; Ⅱ (7837) : 1045.

［6］Bird SD，Doevendans PA, VanRooijen MA, et al. The human adult cardiomyocyte phenotype［J］. Kojima M , Shiogima Z, Yamagaki T , et al.Angiotensin Ⅱ receptor antagonists TCV-116induce regression of hypertensive left ventricular hypertrophy in vivo and inhibits the intracellular signaling pathway of stretch-mediated cardiomyocyte hypertrophy in vitro. Circulation, 1994;89: 2204.

［7］Yoshiyama M , Kim S, Yamagishi H, et al.Cardioprotective effect of the angiotensin Ⅱtype Ⅰ receptor antagonist TCV-116 on ischemia-reperfusion injury. Am Heart J 1994;128: 1.

[8]Sudhir K, MacGregor JS, Gupta M , et al. Effect of selective angiotensin Ⅱ receptor antagonism and angiotensin coverting enzyme inhibition on the coronary vasculature in vivo-intravascular two-dimensional and Doppler ultrasound studies. Circulation, 1993; 87: 931.

[9]Crogier I, Ikram H, Awan N , et al. Losartan in heart failure, hemodynamic effects and tolerability. Circulation , 1995; 91: 691.

[10]Christem Y, Waeber B, Nussberger J , et al.Oral administration of Dup753, a specific angiotensin Ⅱ receptor antagonist, to normal male volunteers (Inhibition ) of pressor response to exogenous A Ⅰ and A Ⅱ. Circulation, 1991; 83: 1333.

[11]Re R, Rovigatt U. New approaches to the study of the cellular biology of the cardiovascular system. Circulation, 1988; 77 (Suppl) : 1.

［12］Schieffer B, Winger A , Meybrunn M , et al.Comparative effects of chronic angiotension-converting enzyme inhibition and angiotensin Ⅱ type receptor blockade on cardiac remodeling after myocardial infarction in the rat. Circulation, 1994; 89: 2273.

备注/Memo

备注/Memo:
收稿 1995-08-24
更新日期/Last Update: 1997-01-01